Mounjaro & Wegovy have shown great results for weight loss. But some people notice another change beyond the scales during significant weight loss: their face looks slimmer, more hollow or less plump than before. This is sometimes referred to as “Ozempic face”...

Losing weight can be a challenging journey, especially when using medications like GLP-1 receptor agonists such as Mounjaro and Wegovy. One often overlooked aspect is Vitamin D, a vital nutrient that supports many bodily functions...

Weight loss medications like Wegovy and Mounjaro, which belong to the GLP-1 class, have gained attention for their ability to support appetite control and improve metabolic health. Yet, many women notice that their weight loss progress can fluctuate throughout their menstrual cycle. Understanding how the menstrual cycle affects the effectiveness of GLP-1 medications can help women manage these changes and maintain steady progress. This article explores the interaction between

Mounjaro... Wegovy... Ozempic. Big names in a growing industry. But are they in for some strong competition? Retatrutide is coming...

Starting a weight loss journey with medications like Wegovy and Mounjaro often brings exciting early results. Many people notice a quick drop in pounds during the first few weeks. This initial weight loss can feel motivating, but it’s important to understand what’s really happening in the body....

As temperatures rise, many people may notice changes in their body weight, appetite, workout performance, and even food cravings. This will be more noticeable when you are on medications such as Wegovy or Mounjaro.

Mounjaro (Tirzepatide) has been given the title of a life-changing drug, helping some people lose up to 20% of their body weight. But what if the scales have stopped moving for you? Weight loss slow or stalled? Keep reading... Not seeing results with weight loss medications can be frustrating and discouraging. It may seem like the medication isn't effective. However, you're not alone, and there's often a reason why your weight loss has plateaued. This article will explain why

Reaching your target weight is a fantastic achievement that you should be proud of. But does your Mounjaro journey end there? Keeping the weight off is equally as important as losing it. Finding the right Mounjaro maintenance dose is key to sustainable weight management...

GLP-1 medications such as Mounjaro and Wegovy offer numerous advantages for achieving a healthy body weight, such as curbing your appetite and diminishing cravings. However, reducing food intake can make it challenging to fulfil nutritional needs. This is where supplements can be beneficial...

Mounjaro, Orlistat, Wegovy and Xenical are all licensed weight loss and weight management medications in the UK but we often get asked - can you take any of them together and is it safe to do so?

Results of Retatrutide show promising outcomes for those wanting to loose weight and control their Type 2 diabetes...

Results of a late-stage trial show that Type 2 diabetes patients using Eli Lilly’s highly anticipated next-generation weight-loss drug Retatrutide experienced a significant reduction in blood-sugar levels and weight loss...

New research shows that weight-loss drugs could treat addiction to alcohol, cigarettes, gambling and drugs. Experts believe the way the GLP-1 and GIP blockbuster weight loss medications work on the brain’s reward pathway can help reduce cravings for many different substances, not just food. Mounjaro, a GLP-1 Receptor Agonist that helps aid weight loss Glucagon-like peptide-1 receptor agonists (GLP-1s), such as Wegovy, and glucose-dependent insulinotropic polypeptide (GIP) li

GLP-1 receptor agonists help reduce hunger and improve blood sugar control, making it easier to lose weight. However, these drugs do not change the underlying behaviours that influence weight. Once the medication is stopped or reduced, old habits can return, increasing the chance of weight regain...

GLP-1 medications like Mounjaro and Wegovy have become popular for managing weight and blood sugar levels. While effective, these drugs often come with side effects such as nausea, diarrhea, acid reflux, and sulphur burps. What many people don’t realize is that certain foods and drinks can make these side effects worse. In particular, diets high in saturated fats and sugary beverages like fizzy drinks and alcohol can increase discomfort. Understanding how these dietary choice

Weight loss medications like Mounjaro and Wegovy have become popular tools for managing weight. These GLP-1 receptor agonists help reduce appetite and improve blood sugar control, supporting effective weight management. Yet, one challenge many face during weight loss is muscle loss, which can affect strength, metabolism, and overall health. Understanding how protein and a balanced diet play a role in preserving muscle mass during weight loss is essential for anyone using thes

Weight loss is often seen as a quick fix, a goal to achieve through the latest fad diet or a new supplement. Yet, many people find themselves caught in a cycle of failed diets and temporary results. The truth is that lasting weight loss depends far more on changing your habits and mindset than on any short-term plan. Sustainable lifestyle changes build a foundation for long-term weight management and overall well-being. This post explores how shifting your mindset and devel

You may feel hesitant when it comes to travelling with this treatment but we have broken down the best ways to stay on track with your treatment when you go away. You can enjoy your time away and take your medication worry-free.

The "King Kong" of weight loss medications, Mounjaro (tirzepatide), is a dual GIP and GLP-1 receptor agonist licensed in the UK for treating type 2 diabetes mellitus and for weight loss. As with any medication affecting pancreatic function, questions have emerged regarding potential links between Mounjaro and pancreatic cancer. Current evidence from clinical trials and regulatory reviews does not establish a causal relationship between tirzepatide and pancreatic malignancy. L

The "King Kong" of weight loss medications, Mounjaro (tirzepatide), is a dual GIP and GLP-1 receptor agonist licensed in the UK for treating type 2 diabetes mellitus and for weight loss. As with any medication affecting pancreatic function, questions have emerged regarding potential links between Mounjaro and pancreatic cancer. Current evidence from clinical trials and regulatory reviews does not establish a causal relationship between tirzepatide and pancreatic malignancy. L